Dallas-based Celanese agreed to supply its VitalDose drug delivery platform for use as a component in Gluakos’ iDose TR. The iDose TR serves as a micro-invasive intraocular implant for lowering intraocular pressure. It treats patients with primary open-angle glaucoma or ocular hypertension.
Get the full story at our sister site, Drug Delivery Business News.